ErbB2/Her2 Antibody (4D5-8 (trastuzumab)), DyLight 650, Novus Biologicals™

ErbB2/Her2

Monoclonal

DyLight 650

50mM Sodium Borate with 0.05% Sodium Azide

ERBB2

A431 cells (human epidermoid carcinoma) (over)expressing EGFR.

0.1 mL

Primary

Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.

Store at 4°C in the dark.

Flow Cytometry, ELISA, Immunohistochemistry

4D5-8 (trastuzumab)

Flow Cytometry, ELISA, Immunohistochemistry

CD340, CD340 antigen, c-erb B2/neu protein, EC 2.7.10, EGFR2, HER-2, HER2EC 2.7.10.1, herstatin, Metastatic lymph node gene 19 protein, MLN 19, MLN19, NEUHER-2/neu, neuroblastoma/glioblastoma derived oncogene homolog, NGLTKR1, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, receptor tyrosine-protein kinase erbB-2, Tyrosine kinase-type cell surface receptor HER2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian)

Human

Protein A purified

Breast Cancer, Cancer, Cellular Markers, Core ESC Like Genes, Oncogenes, Phospho Specific, Protein Kinase, Stem Cell Markers, Tumor Suppressors

2064.0

Human

IgG1 κ